Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Journal of Cancer Research and Therapeutics|August 23, 2019
Prevalence of <i>MET</i> exon 14 skipping mutation in pulmonary sarcomatoid carcinoma patients without common targetable mutations: A single-institute studyYongfeng Yu, Qing Zhang, Jie Zhang, et al.
European Journal of Cancer (Oxford, England : 1990)|May 11, 2010
Antisense treatment of IGF-IR enhances chemosensitivity in squamous cell carcinomas of the head and neckShiguo Liu, Fengling Jin, Wuxing Dai, et al.
Anti-Cancer Drugs|July 9, 2019
Long-term efficacy of afatinib in a patient with squamous cell carcinoma of the lung and multiple ERBB family aberrations: afatinib in ERBB+ lung squamous cell carcinomaHong Jian, Yuchen Han, Yongfeng Yu, et al.
Zhongguo Fei AI Za Zhi = Chinese Journal of Lung Cancer|September 20, 2012
[Gemcitabine combined with vinorelbine in the treatment of refractory patients with advanced non-small cell lung cancer: a multi-center retrospective study]Shun Lu, Li Zhang, Yongfeng Yu, et al.
International Journal of Medical Sciences|February 25, 2021
Distinct profile of cell-free DNA in malignant pleural effusion of non-small cell lung cancer and its impact on clinical genetic testingYongfeng Yu, Jie Qian, Lan Shen, et al.
Therapeutic Advances in Medical Oncology|December 25, 2023
Chinese multidisciplinary expert consensus on the management of adverse drug reactions associated with savolitinibLi Zhang, Yongsheng Wang, Lizhu Lin, et al.
Pediatric Surgery International|February 4, 2011
Chinese pediatric and adolescent primary tracheobronchial tumors: a hospital-based studyYongfeng Yu, Zhengbo Song, Zhiwei Chen, et al.
Lung Cancer (Amsterdam, Netherlands)|August 14, 2025
Dacomitinib in the treatment of EGFR-mutated non-small cell lung cancer with brain metastases: an open-label, multicenter, phase II studyYongfeng Yu, Yueyin Pan, Jianya Zhou, et al.
Springerplus|July 8, 2016
Frequencies of ALK rearrangements in lung adenocarcinoma subtypes: a study of 2299 Chinese casesYongfeng Yu, Zhengping Ding, Lei Zhu, et al.
Frontiers in Oncology|December 28, 2020
Comprehensive Molecular Characterizations of Chinese Patients With Different Subtypes of Lung Squamous Cell CarcinomaJie Qian, Rongrong Chen, Ruiying Zhao, et al.
Pageof 9